CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
Episodes 316-330 of 739
Driving Progress in Cardiology: Exploring the Role of FXI in Acute Coronary Syndromes & Beyond
CME/CEDriving Progress in Cardiology: Exploring the Role of FXI in Acute Coronary Syndromes & Beyond
Expert Perspectives From AUA 2025: Contextualizing the Evolving Landscape of Bladder Cancer
CME/CEExpert Perspectives From AUA 2025: Contextualizing the Evolving Landscape of Bladder Cancer
Cracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure
CME/CECracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure
Novel Therapies in Managing Patients With Cardiovascular-Kidney-Metabolic Syndrome and Heart Failure
Broadcast ReplayNovel Therapies in Managing Patients With Cardiovascular-Kidney-Metabolic Syndrome and Heart Failure
Advancing Care in Non-Clear Cell RCC: Optimizing ICI and TKIs
CME/CEAdvancing Care in Non-Clear Cell RCC: Optimizing ICI and TKIs
New Frontiers in the Treatment of DMD Across the Age Spectrum
CME/CENew Frontiers in the Treatment of DMD Across the Age Spectrum
- advertisement
Insights from Experts: Preventing and Managing CMV Post-Solid Organ Transplant
CME/CEInsights from Experts: Preventing and Managing CMV Post-Solid Organ Transplant
New Strategies for Individualizing Treatment in DME
CME/CENew Strategies for Individualizing Treatment in DME
From Doctor-Speak to Patient-Speak: Bridging the Communication Gap
CME/CEFrom Doctor-Speak to Patient-Speak: Bridging the Communication Gap
Time Is Bone: Making the Case for Early Anabolic Treatment in Osteoporosis
CME/CETime Is Bone: Making the Case for Early Anabolic Treatment in Osteoporosis
Treatment Advances in Generalized Myasthenia Gravis: A Pathophysiology-Driven Framework Leveraging FcRn Therapeutics
CME/CETreatment Advances in Generalized Myasthenia Gravis: A Pathophysiology-Driven Framework Leveraging FcRn Therapeutics
- advertisement
An Overview of Current and Emerging Treatment Options for Hemophilia A & B
MinuteCE®An Overview of Current and Emerging Treatment Options for Hemophilia A & B
The Impact of Hemophilia Across Patients’ Lives
MinuteCE®The Impact of Hemophilia Across Patients’ Lives
Evaluating Novel Factor Replacement Strategies: Extended and Ultra-Half-Life Factors and Factor Mimetics
MinuteCE®Evaluating Novel Factor Replacement Strategies: Extended and Ultra-Half-Life Factors and Factor Mimetics













































































